CIS43LS monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CIS43LS monoclonal antibody, covering 2024-05-02 to 2024-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali [Phase 2]